Literature DB >> 15993515

Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice.

Oliver Ambrée1, Chadi Touma, Nicole Görtz, Kathy Keyvani, Werner Paulus, Rupert Palme, Norbert Sachser.   

Abstract

Alzheimer's disease (AD) is not only characterized by cognitive decline and neuropathological changes, but also by non-cognitive behavioral symptoms like restlessness, sleep disturbance, and wandering. These symptoms are categorized in the "Behavioral and Psychological Symptoms of Dementia" (BPSD). We investigated transgenic and wildtype mice of an APP transgenic mouse model of AD (TgCRND8) with respect to 24 h activity and spontaneous home cage behavior at 30, 60, 90 and 120 days of age. At all test days, transgenic and wildtype animals differed significantly with respect to activity patterns. In addition, activity rhythms changed distinctly in transgenic mice with increasing age. Transgenic mice also clearly showed more stereotypic behavior, which correlated significantly at 90 and 120 days of age with elevated corticosterone metabolite concentrations in fecal samples. Activity patterns in TgCRND8 mice resemble altered rhythms of activity in AD patients. Stereotypic behaviors may be caused by the same mechanisms as non-cognitive behavioral symptoms of AD. Thus, it is likely that analogies to BPSD that precede Abeta pathology are found in APP-overexpressing TgCRND8 mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993515     DOI: 10.1016/j.neurobiolaging.2005.05.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  31 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

2.  Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

Authors:  Beverly M Francis; John Kim; Meredith E Barakat; Stephan Fraenkl; Yeni H Yücel; Shiyong Peng; Bernadeta Michalski; Margaret Fahnestock; Joanne McLaurin; Howard T J Mount
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

3.  Decreased rhythmic GABAergic septal activity and memory-associated theta oscillations after hippocampal amyloid-beta pathology in the rat.

Authors:  Vincent Villette; Frédérique Poindessous-Jazat; Axelle Simon; Clément Léna; Elodie Roullot; Brice Bellessort; Jacques Epelbaum; Patrick Dutar; Aline Stéphan
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

4.  Mouse Behavior Tracker: An economical method for tracking behavior in home cages.

Authors:  Sudheer K Tungtur; Natsuko Nishimune; Jeff Radel; Hiroshi Nishimune
Journal:  Biotechniques       Date:  2017-11-01       Impact factor: 1.993

5.  Changes in the physiology of CA1 hippocampal pyramidal neurons in preplaque CRND8 mice.

Authors:  Robert Wykes; Abigail Kalmbach; Marina Eliava; Jack Waters
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

Review 6.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

Review 7.  Mammalian sleep genetics.

Authors:  Jessica M Kelly; Matt T Bianchi
Journal:  Neurogenetics       Date:  2012-09-14       Impact factor: 2.660

Review 8.  Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology.

Authors:  Makoto Ishii; Costantino Iadecola
Journal:  Cell Metab       Date:  2015-09-10       Impact factor: 27.287

Review 9.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

Review 10.  Alzheimer's Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment.

Authors:  Tsuyoshi Nakai; Kiyofumi Yamada; Hiroyuki Mizoguchi
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.